Raue, Katharina
Rohdich, Nadja
Hauck, Daniela
Zschiesche, Eva
Morelli, Simone
Traversa, Donato
Di Cesare, Angela
Roepke, Rainer K. A.
Strube, Christina
Funding for this research was provided by:
MSD Animal Health
Projekt DEAL
Article History
Received: 20 November 2020
Accepted: 23 January 2021
First Online: 16 February 2021
Ethics approval and consent to participate
: Animal experiments to evaluate the drug combination in cats were approved by the ethics commission of the Institutional Animal Care and Use Committee (IACUC) of the German Lower Saxony State Office for Consumer Protection and Food Safety (Niedersaechisches Landesamt fuer Verbraucherschutz und Lebensmittelsicherheit) under reference number 33.19-42502-04-18/3002. Animal husbandry and handling complied with the European Commission guidelines for the accommodation of animals used for experimental and other scientific purposes.The activities on experimental infected snails and the larvae collection from naturally infected cats were approved by the Italian Ethical committee CEISA (Committee on Animal Research and Ethics of the Universities of Chieti-Pescara, Teramo L’Aquila and of the Experimental Zooprophylactic Institute of Abruzzo-Molise) under reference number UNCHD12 n. 311B-11/07/2018 as well as the Italian Ministry of Health (Ministero della Salute, Direzione Generale Sanità Animale e dei Farmaci Veterinari) under reference number DGSAF 0018252-P-24/07/2018.
: Not applicable.
: NR, EZ and RKAR are employees of MSD Animal Health. KR, DH, DT, SM, ADC and CS declare that there is no conflict with commercial interests. DT, SM and ADC declare that the snail infection and breeding did not coincide with other similar laboratory procedures for the cat lungworm <i>Aelurostrongylus abstrusus</i>.